Is Marijuana aka Cannabis Addictive?
Posted on November 18th, 2025 to Uncategorized by Galina German Innes
The short answer is yes, cannabis (also known as marijuana, weed, zaza, pot, Mary Jane, herb, ganja, marihuana, etc) can be addictive. However, recent research does not frame cannabis as universally addictive in the way opioids, nicotine, or alcohol can be. Habitual or heavy use of cannabis can result in the development of tolerance and dependence. A person may need more and more cannabis to achieve the same effects. Cannabis can be problematic for those individuals who start consuming early in life, those who tend to over-consume, or those who are pre-disposed to addiction. However, many people who consume cannabis do not become addicted. Because cannabis/marijuana is still federally illegal and research on the matter is lacking, major gaps remain in the scientific understanding of how cannabis affects our health and our bodies. More studies are necessary to fully understand this question.
US Widespread Cannabis Use
In 1996, California became the first state in United States to legalize medical cannabis. Colorado became the first state to legalize recreational marijuana in 2014. Medical cannabis is now legal in 40 states and the District of Columbia; recreational marijuana is legal in 24 States and Washington D.C. New York legalized recreational cannabis on March 31, 2021, when Governor Andrew Cuomo signed the Marihuana Regulation and Taxation Act (MRTA) into law. Licensed adult, recreational use did not begin until December 29, 2022. In June 2023, Stage One was the 11th Adult-Use Recreational Cannabis Dispensary to open in the State of New York.
Historically, cannabis has been used recreationally for its mind-altering effects, which can include enhanced senses, body relaxation and changes in mood. In some states, doctors prescribe marijuana for medicinal uses such as reducing muscle spasms, pain, nausea, and vomiting. Many older adults turn to cannabis for chronic pain, insomnia and anxiety. Currently, approximately 13% of U.S. adults regularly use cannabis products. People in mid-to-late adolescence are most likely to begin using cannabis.
What Are The Benefits And Side Effects of Cannabis/Marijuana?
Many studies on cannabis use show evidence supporting its medicinal benefits. For example, it has been found to reduce muscle spasms associated with multiple sclerosis. Cannabis has also been shown to reduce nausea and vomiting that often results from chemotherapy. Immediate (acute) effects of cannabis may include but are not limited to: pain relief, stimulated appetite, reduced nausea and vomiting, reduced anxiety, mood elevation, and body relaxation. THC has gotten a bad rap over the years, but in small doses cannabis can be therapeutic.
As with any medicine, cannabis can also be problematic. Some negative side effects may include but not limited to: rapid heart beat, low blood pressure, bloodshot eyes, slowed digestion, hunger or munchies, muscle relaxation, dry mouth, dizziness, hallucinations, paranoia, and we all know that long term smoking may harm the lungs. Cannabis may also have harmful, long and short term effects, such as paranoia and memory loss, and it can disrupt a user’s life and relationships. For some individuals, frequent marijuana use can lead to development of physiological dependence, withdrawal syndrome, and addiction.
Why Can Cannabis (Marijuana) Be Addictive?
Cannabis is a plant that contains compounds called cannabinoids. Some cannabinoids are psychoactive, meaning they act on the brain to modify mood or consciousness. Cannabis is usually smoked or vaporized and inhaled. It can also be consumed via tea, baked goods, candies, or other edible means. Long term, persistent cannabis use is associated with physiological changes in the brain. The main psychoactive ingredient, THC, appears to be responsible for cannabis’ reinforcing properties and a primary contributor to its addiction. Results from empirical studies have shown that THC stimulates neurons in the reward system to release the signaling chemical (neurotransmitter) dopamine at levels higher than typically observed in response to natural rewarding stimuli. Alterations in dopamine signaling/levels of dopamine are generally associated with other drugs of addiction.
About 14.2 million people (approximately 5% of the US population), aged 12 or older, struggled with marijuana addiction in 2020. An individual who regularly uses marijuana may develop Cannabis Use Disorder (CUD), where cannabis use becomes uncontrollable and begins to impact normal daily functions, such as failure to fulfill role responsibilities at home or work, physical dependence, and health problems. Most people who consume cannabis do not become addicted to it. However, research shows that 1 in 10 adults who use marijuana will develop cannabis addiction or a CUD (with a bit higher risk for people who begin using marijuana before the age of 18). In 2019, 11% of people who received substance use treatment reported marijuana as their primary substance of use.
What is Cannabis Use Disorder (CUD)?
Cannabis Use Disorder can span from mild, to moderate, to severe. Severe forms of CUD are often referred to as marijuana/cannabis addiction due to compulsive drug use behavior despite the negative impact on aspects of one’s life, including significant impairment across life domains—like interpersonal relationships, work and/or school performance, and negative effects on psychological and physical health.
One of the most revealing windows into cannabis addiction risk appears when examining how cannabis use and mental health interact. The large Danish study published in JAMA Psychiatry in 2023, “Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder,” followed 6.65 million people over more than two decades. The study does not claim that occasional cannabis use triggers psychiatric illness. However, it does show that when cannabis use escalates to CUD, it is linked to elevated risk of both depression and bipolar disorder.
These findings illustrate that addiction does not exist in isolation. Individuals who develop CUD may already have underlying vulnerabilities, biological, psychological, or social issues that make both dependence and mood disorders more likely. The Jama Psychiatry study strengthens the idea that problematic cannabis use is not merely recreational behavior gone awry but part of a broader pattern of emotional, cognitive, and environmental pressures. Other genetic studies suggest that developing cannabis addiction is hereditary. A Yale Medicine led study identified several gene variants that increase risk of cannabis dependence. However, more research is needed in order to confirm the findings and understand how these genetic factors might contribute to cannabis dependence or addiction.
Zooming out from individual behavior reveals broader trends in how cannabis addiction appears around the world. The 2024 study “Global Epidemiology of Cannabis Use Disorders and Its Trend from 1990 to 2019”, published in the Journal of Family Medicine and Primary Care, paints an expansive picture of rising CUD prevalence. From 1990 to 2019, global CUD cases climbed from roughly 17 million to nearly 24 million. The highest rates consistently appeared in North America, while steep increases emerged in regions undergoing rapid cultural change.
The study highlights a persistent concentration of CUD among individuals aged fifteen to twenty-four. Youth, with their developing brains and shifting identities, appear particularly susceptible to patterns of use that become compulsive. The global data do not frame cannabis as uniquely or overwhelmingly addictive. Instead, they show that in environments where cannabis is more available, normalized, or potent, more individuals (especially young ones) develop patterns consistent with dependence.
Potency, Preference, and Behavioral Patterns
Public conversations often highlight potency as a key factor driving addiction. However, research complicates this narrative. In 2023, “High Potency Cannabis Use, Mental Health Symptoms and Cannabis Dependence: Triangulating the Evidence” was published in Addiction, comparing cannabis users’ preferred potency with laboratory tested THC levels. Their conclusion was surprisingly modest: people who preferred high-potency cannabis were slightly more likely to show dependence symptoms. Actual measured THC concentration did not predict dependence. Neither the self-reported nor measured potency correlated with psychosis-like symptoms.
Self-Medication and the Reinforcement of Use
Another crucial driver of addiction is why people reach for cannabis in the first place. Many adults do not use cannabis for euphoria alone; they use it to regulate pain, stress, anxiety, insomnia, or low mood. This self-medicating approach plays a significant role in repeated use, and repeated use is the substrate upon which addiction forms.
The 2023 BMC Public Health study “Association of Self-Reported Use of Cannabis for the Purpose of Improving Physical, Mental, and Sleep Health With Problematic Cannabis Use Risk,” surveyed young adults who used cannabis for at least one health-related purpose. Mental health relief was the most common motive, followed closely by sleep and physical ailments. The strongest predictor of problematic use was physical-health self-medication, although all categories were associated with elevated risk.
Self-medication creates a reinforcing cycle: symptoms prompt use, use provides short-term relief, and relief increases the likelihood of using again the next day. Over time, this loop can deepen into dependence, not necessarily because cannabis is acutely addictive but because it becomes integrated into the user’s emotional or physical coping system.
Legalization, Accessibility, and Modern Patterns of Use
As cannabis becomes more available, more standardized and more socially accepted, patterns of addiction tend to shift. “Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal,” published in JAMA Network Open in 2023, assessed cannabis use among primary-care patients in Washington State. They found that about 21 percent of adults using cannabis in the past thirty days met criteria for CUD, with moderate to severe cases concentrated among individuals who combined medical and non-medical use or those who used inhaled forms frequently. This study clarifies an important distinction: legalization does not eliminate addiction risk. Instead, it shapes the environment in which use occurs. When products are easier to obtain and when social norms encourage regular consumption for both pleasure and wellness, the number of individuals who drift from occasional, regular or compulsive use grows accordingly.
Conclusion
The recent research does not frame cannabis as universally addictive in the way opioids, nicotine, or alcohol can be. Cannabis lacks the severe physiological withdrawal seen in those substances, and many people use it without developing dependence. Yet the data also shows that addiction remains a real and measurable risk. The likelihood increases with frequent use, use motivated by medical symptom relief and self-medication, younger age of initiation, and patterns that reflect coping rather than recreation. Due to the fact that cannabis/marijuana is still federally illegal, thorough research on the matter is lacking. Major unknowns remain in the scientific understanding of how cannabis affects our health, our bodies, and our lives.
SOURCES:
- American Addiction Centers. “Marijuana Addiction Facts: Is Marijuana Addictive?” Dr. Autumn Rae Florimbio (April 2025). https://americanaddictioncenters.org/marijuana-rehab/is-it-addictive
- Yale Medicine. “Cannabis/Marijuana Use Disorder.” https://www.yalemedicine.org/conditions/marijuana-use-disorder
- Stanford Medicine. “Cannabis and Older Adults: Five things medical experts want you to know.” Rachel Tompa. (October 2025). https://med.stanford.edu/news/insights/2025/10/cannabis-marijuana-seniors-cautions.html.
- Cleveland Clinic. “Cannabis Use Disorder” (April 2024) https://my.clevelandclinic.org/health/diseases/cannabis-use-disorder.
- JAMA Psychiatry. “Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder.” Various Authors (May 2023). https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2804862
- National Library of Medicine National Center for Biotechnology Information. Pub Med “High potency cannabis use, mental health symptoms and cannabis dependence: Triangulating the evidence.” Various Authors. (September 2023). https://pubmed.ncbi.nlm.nih.gov/37121087/
- Journal of Family Medicine and Primary Care. “Global epidemiology of cannabis use disorders and its trend from 1990 to 2019: Benchmarking analysis of the global burden of disease study.” Various Authors. (March 2024). https://journals.lww.com/jfmpc/fulltext/2024/13030/global_epidemiology_of_cannabis_use_disorders_and.14.aspx
- BMC Public Health. “Association of self-reported use of cannabis for the purpose of improving physical, mental, and sleep health with problematic cannabis use risk.” (August 2023). https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-16324-0
- JAMA Network Open. “Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.” Various Authors. (August 2023). https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2808874
Copyright © 2026 Stage One Dispensary |
Site by CannaPlanners